Frequently Asked Questions about Roche Holding AG (RHHBY)

Name: Roche Holding AG (RHHBY) Institutional Financial Dataset
Creator: Olyth
License: https://olyth.xyz

Question 1

What does Roche Holding AG (RHHBY) do?

Accepted Answer

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Switzerland, Germany, the United States, Austria, Netherlands, the United Kingdom, France, Belgium, and internationally. The company offers pharmaceutical products for treating oncology, neuroscience, infectious, immunolog...

Question 2

Is Roche Holding AG (RHHBY) a good stock to buy?

Accepted Answer

Olyth's institutional analysis of RHHBY reveals an Altman Z-Score of 4.68 and a Piotroski F-Score of 6/9. These metrics, combined with its 5-year revenue trend ($63.36B most recent), help investors decide if RHHBY fits their risk profile.

Question 3

What is the current P/E ratio for RHHBY?

Accepted Answer

As of the latest trading session, Roche Holding AG (RHHBY) has a trailing P/E ratio of 19.50.

Question 4

Who is the CEO of Roche Holding AG?

Accepted Answer

The current Chief Executive Officer of Roche Holding AG is Thomas Schinecker.

Question 5

What was RHHBY's revenue for the last 5 years?

Accepted Answer

According to its latest income statements, Roche Holding AG reported annual revenues of $63.36B (2025), $62.40B (2024), $60.44B (2023), $65.81B (2022), $62.80B (2021) respectively.

Question 6

Does RHHBY pay a dividend?

Accepted Answer

Roche Holding AG currently pays a dividend to its shareholders, with a trailing dividend yield of 3.11%.

Question 7

How much debt and cash flow does RHHBY have?

Accepted Answer

In its latest reporting period, Roche Holding AG generated $13.45B in Free Cash Flow against a total debt load of $31.67B.

Question 8

What is the Price-to-Book (P/B) ratio of Roche Holding AG?

Accepted Answer

The Price-to-Book (P/B) ratio for Roche Holding AG (RHHBY) is currently 7.43.

Question 9

What is the Price-to-Sales (P/S) ratio of RHHBY?

Accepted Answer

Based on trailing twelve-month data, Roche Holding AG (RHHBY) trades at a Price-to-Sales (P/S) ratio of 4.08.

Question 10

What is Roche Holding AG's Return on Equity (ROE)?

Accepted Answer

Roche Holding AG (RHHBY) has a Return on Equity (ROE) of 41.23%, representing its profitability relative to shareholder equity.

Period	Total Assets	Total Liabilities	Total Equity	Total Debt	Net Debt
2025-12	100.8B	62.9B	37.9B	31.7B	26.1B
2024-12	101.8B	65.6B	36.2B	36.4B	29.4B
2023-12	90.5B	57.2B	33.3B	30.8B	25.4B
2022-12	88.2B	56.1B	32B	26.5B	21.6B
2021-12	92.3B	64B	28.3B	32.6B	25.7B

Period	Total Assets	Total Liabilities	Total Equity	Total Debt	Net Debt
2025-12	100.8B	62.9B	37.9B	31.7B	26.1B
2024-12	101.8B	65.6B	36.2B	36.4B	29.4B
2023-12	90.5B	57.2B	33.3B	30.8B	25.4B
2022-12	88.2B	56.1B	32B	26.5B	21.6B
2021-12	92.3B	64B	28.3B	32.6B	25.7B